Lista de obras -

An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study.

artículo científico publicado en 2017

Assembly 9: allied respiratory professionals.

scientific article published on December 2016

Assessment of dyspnea in asthma: validation of The Dyspnea-12.

artículo científico publicado en 2011

Contemporary challenges for specialist nursing in interstitial lung disease.

artículo científico publicado en 2018

Cough in idiopathic pulmonary fibrosis

artículo científico publicado en 2016

Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary Fibrosis.

scientific article published on 18 April 2016

Detecting anxiety and depression in patients diagnosed with an interstitial lung disease. Can we do better?

artículo científico publicado en 2014

Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease.

artículo científico publicado en 2010

Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial

scientific article published on 28 August 2018

Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis.

artículo científico publicado en 2017

Feasibility, utility and symptom impact of modified mindfulness training in sarcoidosis.

artículo científico publicado en 2018

Gaps in care of patients living with pulmonary fibrosis: a joint patient and expert statement on the results of a Europe-wide survey

artículo científico publicado en 2019

Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial

artículo científico publicado en 2021

Letter from the UK

artículo científico publicado en 2020

Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study

artículo científico publicado en 2015

Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis

artículo científico publicado en 2013

Outcome Measures for Clinical Trials in Interstitial Lung Diseases

artículo científico publicado en 2015

Palliative care in interstitial lung disease: living well.

artículo científico publicado en 2017

Patient-centred management in idiopathic pulmonary fibrosis: similar themes in three communication models

artículo científico

Qualitative European survey of patients with idiopathic pulmonary fibrosis: patients' perspectives of the disease and treatment.

artículo científico publicado en 2016

Reply: Daily Home Spirometry: A New Milestone in the Field of Pulmonary Fibrosis.

artículo científico publicado en 2016

Unmet needs in the treatment of idiopathic pulmonary fibrosis-insights from patient chart review in five European countries

artículo científico publicado en 2017

Use of the patientMpower App With Home-Based Spirometry to Monitor the Symptoms and Impact of Fibrotic Lung Conditions: Longitudinal Observational Study

scientific article published on 20 November 2020

What's it like to live with idiopathic pulmonary fibrosis? Ask the experts

artículo científico publicado en 2016

Lista de obras de

An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study.

Assembly 9: allied respiratory professionals.

Assessment of dyspnea in asthma: validation of The Dyspnea-12.

Contemporary challenges for specialist nursing in interstitial lung disease.

Cough in idiopathic pulmonary fibrosis

Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary Fibrosis.

Detecting anxiety and depression in patients diagnosed with an interstitial lung disease. Can we do better?

Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease.

Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial

Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis.

Feasibility, utility and symptom impact of modified mindfulness training in sarcoidosis.

Gaps in care of patients living with pulmonary fibrosis: a joint patient and expert statement on the results of a Europe-wide survey

Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial

Letter from the UK

Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study

Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis

Outcome Measures for Clinical Trials in Interstitial Lung Diseases

Palliative care in interstitial lung disease: living well.

Patient-centred management in idiopathic pulmonary fibrosis: similar themes in three communication models

Qualitative European survey of patients with idiopathic pulmonary fibrosis: patients' perspectives of the disease and treatment.

Reply: Daily Home Spirometry: A New Milestone in the Field of Pulmonary Fibrosis.

Unmet needs in the treatment of idiopathic pulmonary fibrosis-insights from patient chart review in five European countries

Use of the patientMpower App With Home-Based Spirometry to Monitor the Symptoms and Impact of Fibrotic Lung Conditions: Longitudinal Observational Study

What's it like to live with idiopathic pulmonary fibrosis? Ask the experts